Uncommon craniosynostosis syndromes: A review of thirteen conditions

Monographs in Human Genetics

Volumn 19, Issue , 2011, Pages 119-142

  Raam, M S ^a,b   Muenke, M ^a,c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Building 35 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866056483     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000319258     Document Type: Review

References (148)

1. Kimonis V, Gold J-A, Hoffman TL, Panchal J, Boyadjiev SA: Genetics of craniosynostosis. Semin Pediatr Neurol 2007;14:150-161. (Pubitemid 350008077)
2. Cohen MM Jr, MacLean RE: Anatomic, genetic, nosologic, diagnostic, and psychosocial considerations; in Cohen MM Jr, MacLean RE (eds): Craniosynostosis: Diagnosis, Evaluation, and Management, 2nd ed. New York, Oxford University Press, 2000, pp 119-146.
3. Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, et al: Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 1996;14:174-176. (Pubitemid 26338798)
4. Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, et al: A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 1997;60:555-564. (Pubitemid 27097603)
5. Antley R, Bixler D: Trapezoidocephaly, midfacial hypoplasia, and cartilage abnormalities with multiple synostoses and skeletal fractures. Birth Defects Orig Artic Ser 1975;11:397-401.
6. De Lozier CD, Antley RM, Williams R, Green N, Heller RM, et al: The syndrome of multisynostotic osteodysgenesis with long-bone fractures. Am J Med Genet 1980;7:391-403. (Pubitemid 11203644)
7. Lee H-J, Cho D-Y, Tsai F-J, Shen W-C: Antley-Bixler syndrome, description of two new cases and review of the literature. Pediatr Neurosurg 2001;34:33-39. (Pubitemid 32245402)
8. Crisponi G, Porcu C, Piu ME: Antley-Bixler syndrome: Case report and review of the literature. Clin Dysmorphol 1997;6:61-68. (Pubitemid 27041727)
9. Kitoh H, Nogami H, Oki T, Arao K, Nagasaka M, Tanaka Y: Antley-Bixler syndrome: a disorder characterized by congenital synostosis of the elbow joint and the cranial suture. J Pediatr Orthoped 1996;16:243-246. (Pubitemid 26067653)
10. Chun K, Siegel-Bartelt J, Chitayat D, Phillips J, Ray PN: FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet 1998;77:219-224. (Pubitemid 28208442)
11. Gorlin RJ: Patient described by Chun et al. may not present Antley-Bixler syndrome. Am J Med Genet 1999;83:64. (Pubitemid 29104477)
12. Gripp KW, Zackai EH, Cohen MM Jr: Not Antley-Bixler syndrome. Am J Med Genet 1999;83:65-66.
13. Cohen MM Jr: FGFs/FGFRs and associated disorders; in Epstein CJ, Erickson RP, Wynshaw-Boris A (eds): Inborn Errors of Development: The Molecular Basis of Clinical Disorders of Morphogenesis. Oxford, Oxford University Press, 2004, pp 380-400.
14. Reardon W, Smith A, Honour JW, Hindmarsh P, Das D, et al: Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J Med Genet 2000;37:26-32. (Pubitemid 30245870)
15. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, et al: Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 2005;76:729-749. (Pubitemid 40563096)
16. Flück CE, Tajima T, Pandey AV, Arlt W, Okuhara K, et al: Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004;36:228-230. (Pubitemid 38282745)
17. Adachi M, Tachibana K, Asakura Y, Yamamoto T, Hanaki K, Oka A: Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. Am J Med Genet A 2004;128 A: 333-339. (Pubitemid 38988634)
18. Fukami M, Horikawa R, Nagai T, Tanaka T, Naiki Y, et al: Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocr Metab 2005;90:414-426. (Pubitemid 40116690)
19. Kelley RI, Kratz LE, Glaser RL, Netzloff ML, Wolf LM, Jabs EW: Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. Am J Med Genet A 2002;110:95-102.
20. Aleck KA, Bartley DL: Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet 1997;72:253-256. (Pubitemid 27424225)
21. Lopez-Rangel E, Van Allen MI: Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. Birth Defects Res A 2005;73:919-923. (Pubitemid 41739255)
22. Hassell S, Butler MG: Antley-Bixler syndrome: report of a patient and review of literature. Clin Genet 1994;46:372-376. (Pubitemid 24373297)
23. Baller F: Radiusaplasie und Inzucht. Z Menschl Vererbungs Konstit Lehre 1950;29:782-790.
24. Gerold M: Frakturheilung bei einem seltenen Fall kongenitaler Anomalie der oberen Gliedmaßen. Zbl Chir 1959;84:831-834.
25. Ramos Fuentes FJ, Nicholson L, Scott CI Jr: Phenotypic variability in the Baller-Gerold syndrome: report of a mildly affected patient and review of the literature. Eur J Pediatr 1994;153:483-487. (Pubitemid 24210277)
26. Pelias MZ, Superneau DW, Thurmon TF: Brief clinical report: a sixth report (eighth case) of craniosynostosis-radial aplasia (Baller-Gerold) syndrome. Am J Med Genet 1981;10:133-139. (Pubitemid 11031586)
27. Boudreaux JM, Colon MA, Lorusso GD, Parro EA, Pelias MZ: Baller-Gerold syndrome: an 11th case of craniosynostosis and radial aplasia. Am J Med Genet 1990;37:447-450. (Pubitemid 20380821)
28. Galea P, Tolmie JL: Normal growth and development in a child with Baller-Gerold syndrome (craniosynostosis and radial aplasia). J Med Genet 1990;27:784-787. (Pubitemid 120021189)
29. Cohen MM Jr, Toriello HV: Is there a Baller-Gerold syndrome? Am J Med Genet 1996;61:63-64.
30. Quarrell O W J, Maltby EL, Harrison CJ: Baller-Gerold syndrome and Fanconi anemia. Am J Med Genet 1998;75:228-229.
31. Gripp KW, Stolle CA, Celle L, McDonald-McGinn DM, Whitaker LA, Zackai EH: TWIST gene mutation in a patient with radial aplasia and craniosynostosis: further evidence for heterogeneity of Baller-Gerold syndrome. Am J Med Genet 1999;82:170-176. (Pubitemid 29055072)
32. Huson SM, Rodgers CS, Hall CM, Winter RM: The Baller-Gerold syndrome: phenotypic and cytogenetic overlap with Roberts syndrome. J Med Genet 1990;27:371-375.
33. Farrell SA, Paes BA, Lewis M E S: Fanconi anemia in a child previously diagnosed as Baller-Gerold syndrome. Am J Med Genet 1994;50:98-99. (Pubitemid 24081410)
34. Rossbach H-C, Sutcliffe MJ, Haag MM, Grana NH, Rossi AR, Barbosa JL: Fanconi anemia in brothers initially diagnosed with VACTERL association with hydrocephalus, and subsequently with Baller-Gerold syndrome. Am J Med Genet 1996;61:65-67.
35. Van Maldergem L, Siitonen HA, Jalkh N, Chouery E, De Roy M, et al: Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene. J Med Genet 2006;43:148-152. (Pubitemid 43259628)
36. Mégarbané A, Melki I, Souraty N, Gerbaka J, Ghouzzi VE, et al: Overlap between Baller-Gerold and Rothmund-Thomson syndrome. Clin Dysmorphol 2000;9:303-305.
37. Preis S, Majewski F, Korholz D, Gobel U: Osteosarcoma in a 16-year-old boy with Baller-Gerold syndrome. Clin Dysmorphol 1995;4:161-168.
38. Siitonen HA, Kopra O, Kääriäinen H, Haravuori H, Winter RM, et al: Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases. Hum Mol Genet 2003;12:2837-2844. (Pubitemid 37407120)
39. Siitonen HA, Sotkasiira J, Biervliet M, Benmansour A, Capri Y, et al: The mutation spectrum in RECQL4 diseases. Eur J Hum Genet 2009;17:151-158.
40. Wang LL, Gannavarupu A, Kozinetz CA, Levy ML, Lewis RA, et al: Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst 2003;95:669-674. (Pubitemid 36603723)
41. Beare JM, Dodge JA, Nevin NC: Cutis gyratum, acanthosis nigricans and other congenital anomalies. A new syndrome. Br J Dermatol 1969;81:241-247.
42. Stevenson RE, Ferlauto GJ, Taylor HA: Cutis gyratum and acanthosis nigricans associated with other anomalies: a distinctive syndrome. J Pediatr 1978;92:950-952.
43. Hall BD, Cadle RG, Golabi M, Morris CA, Cohen MM Jr: Beare-Stevenson cutis gyrata syndrome. Am J Med Genet 1992;44:82-89.
44. Izakovic J, Leitner S, Schachner LA: What syndrome is this? Beare-Stevenson cutis gyrata syndrome. Pediatr Dermatol 2003;20:358-360.
45. Przylepa KA, Paznekas W, Zhang M, Golabi M, Bias W, et al: Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat Genet 1996;13:492-494. (Pubitemid 26259929)
46. Akai T, Iizuka H, Kishibe M, Kawakami S, Kobayashi A, Ozawa T: A case of Beare-Stevenson cutis gyrata syndrome confirmed by mutation analysis of the fibroblast growth factor receptor 2 gene. Pediatr Neurosurg 2002;37:97-99. (Pubitemid 34977959)
47. Eun S-H, Ha KS, Je B-K, Lee ES, Choi BM, et al: The first Korean case of Beare-Stevenson syndrome with a Tyr375Cys mutation in the fibroblast growth factor receptor 2 gene. J Korean Med Sci 2007;22:352-356.
48. Krepelová A, Baxová A, Calda P, Plavka R, Kapras J: FGFR2 gene mutation (Tyr-375Cys) in a new case of Beare-Stevenson syndrome. Am J Med Genet A 1998;76:362-364. (Pubitemid 28136112)
49. McGaughran J, Sinnott S, Susman R, Buckley MF, Elakis G, et al: A case of Beare-Stevenson syndrome with a broad spectrum of features and a review of the FGFR2 Y375C mutation phenotype. Clin Dysmorphol 2006;15:89-93. (Pubitemid 44481241)
50. Vargas RA, Maegawa GH, Taucher SC, Leite JC, Sanz P, et al: Beare-Stevenson syndrome: two South American patients with FGFR2 analysis. Am J Med Genet A 2003;121 A: 41-46. (Pubitemid 37059340)
51. Wang T-J, Huang C-B, Tsai F-J, Wu J-Y, Lai R-B, Hsiao M: Mutation in the FGFR2 gene in a Taiwanese patient with Beare-Stevenson cutis gyrata syndrome. Clin Genet 2002;61:218-221. (Pubitemid 36372636)
52. Fonseca R, Costa-Lima MA, Cosentino V, Orioli IM: Second case of Beare-Stevenson syndrome with an FGFR2 Ser372Cys mutation. Am J Med Genet A 2008;146 A: 658-660.
53. Slavotinek A, Crawford H, Golabi M, Tao C, Perry H, et al: Novel FGFR2 deletion in a patient with Beare-Stevenson-like syndrome. Am J Med Genet A 2009;149 A: 1814-1817.
54. Upmeyer S, Bothwell M, Tobias JD: Perioperative care of a patient with Beare-Stevenson syndrome. Pediatr Anesth 2005;15:1131-1136. (Pubitemid 43965397)
55. Erol DD, Eser O: The expected difficult intubation of a patient with Beare-Stevenson syndrome. Pediatr Anesth 2006;16:801. (Pubitemid 44365973)
56. Opitz JM, Johnson RC, McCreadie SR, Smith DW: The C syndrome of multiple congenital anomalies. Birth Defects Orig Art Ser 1969;5:161-166.
57. Kaname T, Yanagi K, Chinen Y, Makita Y, Okamoto N, et al: Mutations in CD96, a member of the immunoglobulin superfamily, cause a form of the C (Opitz trigonocephaly) syndrome. Am J Hum Genet 2007;81:835-841. (Pubitemid 47596551)
58. Opitz JM, Putnam AR, Comstock JM, Chin S, Byrne J L B, et al: Mortality and pathological findings in C (Opitz trigonocephaly) syndrome. Fetal Pediatr Pathol 2006;25:211-231. (Pubitemid 44949938)
59. Bohring A, Silengo M, Lerone M, Superneau DW, Spaich C, et al: Severe end of Opitz trigonocephaly (C) syndrome or new syndrome? Am J Med Genet 1999;85:438-446. (Pubitemid 29339938)
60. David G, Sillence D, Hardwick R, Opitz JM: A case of Kabuki (Niikawa-Kuroki) syndrome associated with manifestations resembling C-trigonocephaly syndrome. Am J Med Genet A 2004;130 A: 389-392. (Pubitemid 39441615)
61. Fryns JP, Snoeck L, Kleczkowska A, Van Den Berghe H: Opitz trigonocephaly syndrome and terminal transverse limb reduction defects. Helv Paediatr Acta 1985;40:485-488. (Pubitemid 16166764)
62. Cleper R, Kauschansky A, Varsano I, Frydman M: Váradi syndrome (OFD VI) or Opitz trigonocephaly syndrome: overlapping manifestations in two cousins. Am J Med Genet 1993;47:451-455. (Pubitemid 23286509)
63. Sabry MA, Al Saleh Q, Farah S, Obenbergerova D, Simeonov S, et al: Another Arab patient with overlap of Váradi-Papp/Opitz trigonocephaly syndromes? Am J Med Genet 1997;68:54-57.
64. Preus M, Vekemans M, Kaplan P: Diagnosis of chromosome 3 duplication q23.qter, deletion p25.pter in a patient with the C (trigonocephaly) syndrome. Am J Med Genet 1986;23:935-943. (Pubitemid 16063406)
65. Chu TW, Teebi AS, Gibson L, Breg WR, Yang-Feng TL: FISH diagnosis of partial trisomy 13 and tetrasomy 13 in a patient with severe trigonocephaly (C) phenotype. Am J Med Genet 1994;52:92-96. (Pubitemid 24237338)
66. Chinen Y, Kaname T, Yanagi K, Saito N, Naritomi K, Ohta T: Opitz trigonocephaly C syndrome in a boy with a de novo balanced reciprocal translocation t (3;18) (q13.13;q12.1). Am J Med Genet A 2006;140 A: 1655-1657. (Pubitemid 44148252)
67. Sargent C, Burn J, Baraitser M, Pembrey ME: Trigonocephaly and the Opitz C syndrome. J Med Genet 1985;22:39-45. (Pubitemid 15165325)
68. Temtamy SA: Carpenter's syndrome: acrocephalopolysyndactyly. An autosomal recessive syndrome. J Pediatr 1966;69:111-120.
69. Cohen DM, Green JG, Miller J, Gorlin RJ, Reed JA: Acrocephalopolysyndactyly type II-Carpenter syndrome: clinical spectrum and an attempt at unification with Goodman and Summit syndromes. Am J Med Genet 1987;28:311-324. (Pubitemid 18007175)
70. Perlyn CA, Marsh JL: Craniofacial dysmorphology of Carpenter syndrome: lessons from three affected siblings. Plast Reconstr Surg 2008;121:971-981. (Pubitemid 351642834)
71. Jenkins D, Seelow D, Jehee FS, Perlyn CA, Alonso LG, et al: RAB23 mutations in Carpenter syndrome imply an unexpected role for Hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet 2007;80:1162-1170. (Pubitemid 47579351)
72. Cooper MK, Wassif CA, Krakowiak PA, Taipale J, Gong R, et al: A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 2003;33:508-513. (Pubitemid 36390014)
73. Tarhan E, Oguz H, Safak MA, Samim E: The Carpenter syndrome phenotype. Int J Pediatr Otorhinolaryngol 2004;68:353-357. (Pubitemid 38201620)
74. Batra YK, Rajeev S, Nishtala S, Grover G: Anesthetic implications of Carpenter syndrome (Acrocephalopolysyndactyly type II). Pediatr Anesth 2008;18:1235-1237.
75. Taravath S, Tonsgard JH: Cerebral malformations in Carpenter syndrome. Pediatr Neurol 1993;9:230-234. (Pubitemid 23199474)
76. Ashby T, Rouse GA, De Lange M: Prenatal sonographic diagnosis of Carpenter syndrome. J Ultrasound Med 1994;13:905-909. (Pubitemid 24346955)
77. Balci S, Önol B, Eryilmaz M, Haytoglu T: A case of Carpenter syndrome diagnosed in a 20-week-old fetus with postmortem examination. Clin Genet 1997;51:412-416. (Pubitemid 27267814)
78. Arnaud-López L, Fragoso R, Mantilla-Capacho J, Narros-Núñez P: Crouzon with acanthosis nigricans. Further delineation of the syndrome. Clin Genet 2007;72:405-410. (Pubitemid 47570693)
79. Cohen MM Jr: Let's call it 'Crouzonodermoskeletal syndrome' so we won't be prisoners of our own conventional terminology. Am J Med Genet 1999;84:74.
80. Schweitzer DN, Graham JM Jr, Lachman RS, Jabs EW, Okajima K, et al: Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala-391Glu substitution in FGFR3. Am J Med Genet 2001;98:75-91. (Pubitemid 32041854)
81. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW: Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995;11:462-464.
82. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S: Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994;8:98-103. (Pubitemid 24274068)
83. Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, et al: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994;78:335-342. (Pubitemid 24241100)
84. Superti-Furga A, Eich G, Bucher HU, Wisser J, Giedion A, et al: A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr 1995;154:215-219.
85. Rousseau F, Bonaventure J, Legeal-Mallet L, Pelet A, Rozet J-M, et al: Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994;371:252-254. (Pubitemid 24293024)
86. Jackson CE, Weiss L, Reynolds WA, Forman TF, Peterson JA: Craniosynostosis, midfacial hypoplasia, and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred. J Pediatr 1976;88:963-968.
87. Cross HE, Opitz JM: Craniosynostosis in the Amish. J Pediatr 1969;75:1037-1044.
88. Heike C, Seto M, Hing A, Palidin A, Hu FZ, et al: Century of Jackson-Weiss syndrome: further definition of clinical and radiographic findings in 'lost' descendants of the original kindred. Am J Med Genet 2001;100:315-324. (Pubitemid 32382405)
89. Gorry MC, Preston RA, White GJ, Zhang Y, Singhai VK, et al: Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet 1995;4:1387-1390.
90. Meyers GA, Day D, Goldberg R, Daentl DL, Przylepa KA, et al: FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet 1996;58:491-498.
91. Park W-J, Meyers GA, Li X, Theda C, Day D, et al: Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet 1995;4:1229-1233.
92. Passos-Bueno MR, Sertié AL, Richieri-Costa A, Alonso LG, Zatz M, et al: Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses. Am J Med Genet 1998;78:237-241. (Pubitemid 28307536)
93. Roscioli T, Flanagan S, Kumar P, Masel J, Gattas M, et al: Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature. Am J Med Genet 2000;93:22-28.
94. Tartaglia M, Di Rocco C, Lajeunie E, Valeri S, Velardi F, Battaglia PA: Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders. Hum Genet 1997;101:47-50. (Pubitemid 28014640)
95. Cohen MM Jr: Jackson-Weiss syndrome. Am J Med Genet 2001;100:325-329.
96. Cohen MM Jr: Craniosynostoses: phenotypic/molecular correlations. Am J Med Genet 1995;56:334-339.
97. Winter RM, Reardon W: Lumpers, splitters, and FGFRs. Am J Med Genet 1996;63:501-502.
98. Cohen MM Jr: A matter of reading English. Am J Med Genet 1996;63:503-504.
99. Li X, Lewanda AF, Eluma F, Jerald H, Choi H, et al: Two craniosynostotic syndrome loci, Crouzon and Jackson-Weiss, map to chromosome 10q23-q26. Genomics 1994;22:418-424. (Pubitemid 24258885)
100. Jabs EW, Li X, Scott AF, Meyers G, Chen W, et al: Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1994;8:275-279. (Pubitemid 24338740)
101. Jabs EW: Correction: Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1995;9:451.
102. Jacobsen P, Hauge M, Henningsen K, Hobolth N, Mikkelsen M, Philip J: An (11;21) translocation in four generations with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical, and gene marker study. Hum Hered 1973;23:568-585.
103. Mattina T, Perrotta CS, Grossfeld P: Jacobsen syndrome. Orphanet J Rare Dis 2009;4:9.
104. Tunnacliffe A, Jones C, Le Paslier D, Todd R, Cherif D, et al: Localization of Jacobsen syndrome breakpoints on a 40-Mb physical map of distal chromosome 11q. Genome Res 1999;9:44-52. (Pubitemid 29095147)
105. Fryns JP, Kleczkowska A, Buttiens M, Marien P, Van Den Berghe H: Distal 11q monosomy. The typical 11q monosomy syndrome is due to deletion of subband 11q24.1. Clin Genet 1986;30:255-260. (Pubitemid 17176282)
106. Penny LA, Dell'Aquila M, Jones MC, Bergoffen J, Cunniff C, et al: Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet 1995;56:676-683.
107. Grossfeld PD, Mattina T, Lai Z, Favier R, Jones KL, et al: The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet 2004;129 A: 51-61. (Pubitemid 38989044)
108. Krishnamurti L, Neglia JP, Nagarajan R, Berry SA, Lohr J, et al: Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome. Am J Hematol 2001;66:295-299. (Pubitemid 32210300)
109. Jones C, Slijepcevic P, Marsh S, Baker E, Langdon WY, et al: Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet 1994;3:2123-2130.
110. Jones C, Müllenbach R, Grossfeld P, Auer R, Favier R, et al: Co-localisation of CCG repeats and chromosome deletion breakpoints in Jacobsen syndrome: evidence for a common mechanism of chromosome breakage. Hum Mol Genet 2000;9:1201-1208. (Pubitemid 30248606)
111. Hart A, Melet F, Grossfeld P, Chien K, Jones C, et al: Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000;13:167-177.
112. Raslova H, Komura E, Le Couédic JP, Larbret F, Debili N, et al: FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest 2004;114:77-84. (Pubitemid 39071646)
113. Phillips HM, Renforth GL, Spalluto C, Hearn T, Curtis A R J, et al: Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3, expressed during cardiogenesis. Genomics 2002;79:475-478. (Pubitemid 34274285)
114. Coldren CD, Lai Z, Shragg P, Rossi E, Glidewell SC, et al: Chromosomal microarray mapping suggests a role for BSX and neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome). Neurogenetics 2008;10:89-95.
115. Ye M, Hamzeh R, Geddis A, Varki N, Perryman MB, Grossfeld P: Deletion of JAM-C, a candidate gene for heart defects in Jacobsen syndrome, results in a normal cardiac phenotype in mice. Am J Med Genet A 2009;149 A: 1438-1443.
116. Beighton P, Cremin BJ, Kozlowski K: Osteoglophonic dwarfism. Pediatr Radiol 1980;10:46-50. (Pubitemid 10002727)
117. Greenberg F, Lewis RA: Osteoglophonic dysplasia. J Med Genet 1990;27:213-216.
118. Sklower Brooks S, Kassner G, Qazi Q, Keogh MJ, Gorlin RJ: Osteoglophonic dysplasia: review and further delineation of the syndrome. Am J Med Genet 1996;66:154-162.
119. Santos H, Campos P, Alves R, Torrado A: Osteoglophonic dysplasia: a new case. Eur J Pediatr 1988;147:547-549.
120. Stöß H, Sieber E, Tietze HU: Osteoglophone Skelettdysplasie: Variante einer generalisierten fibrösen Dysplasie? Pathologe 1991;12:161-166.
121. Kelley RI, Borns PF, Nichols D, Zackai EH: Osteoglophonic dwarfism in two generations. J Med Genet 1983;20:436-440. (Pubitemid 14200415)
122. Fairbank T: An Atlas of General Affections of the Skeleton. Edinburgh, Livingstone, 1959.
123. Roberts TS, Stephen L, Beighton P: Osteoglophonic dysplasia: dental and orthodontic implications. Orthod Craniofac Res 2006;9:153-156.
124. White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, et al: Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet 2005;76:361-367. (Pubitemid 40129563)
125. Beighton P: Osteoglophonic dysplasia. J Med Genet 1989;26:572-576. (Pubitemid 19225956)
126. Farrow EG, Davis SI, Mooney SD, Beighton P, Mascarenhas L, et al: Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. Am J Med Genet A 2006;140 A: 537-539. (Pubitemid 43376329)
127. Sugarman G, Vogel MW: Craniofacial and musculoskeletal abnormalities. A questionable connective tissue disease. Synd Iden 1981;7:16-17. (Pubitemid 13218078)
128. Robinson PN, Neumann LM, Demuth S, Enders H, Jung U, et al: Shprintzen-Goldberg syndrome: fourteen new patients and a clinical analysis. Am J Med Genet A 2005;135 A: 251-262. (Pubitemid 40756649)
129. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, et al: A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 and TGFBR2. Nat Genet 2005;37:275-281. (Pubitemid 41716254)
130. Adès LC, Morris LL, Power RG, Wilson M, Haan EA, et al: Distinct skeletal abnormalities in four girls with Shprintzen-Goldberg syndrome. Am J Med Genet 1995;57:565-572.
131. Greally MT, Carey JC, Milewicz DM, Hudgins L, Goldberg RB, et al: Shprintzen-Goldberg syndrome: a clinical analysis. Am J Med Genet 1998;76:202-212. (Pubitemid 28108805)
132. Mégarbané A, Hokayem N: Craniosynostosis and marfanoid habitus without mental retardation: report of a third case. Am J Med Genet 1998;77:170-171.
133. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, et al: Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 2006;355:788-798. (Pubitemid 44285584)
134. Aalberts J J J, Van Den Berg MP, Bergman J E H, Du Marchie Sarvaas GJ, Post JG, et al: The many faces of aggressive aortic pathology: Loeys-Dietz syndrome. Neth Heart J 2008;16:299-304.
135. Robinson PN, Neumann LM, Tinschert S: Response to Kosaki et al., 'Molecular pathology of Shprintzen-Goldberg syndrome'. Am J Med Genet A 2006;140 A: 109-110. (Pubitemid 43054045)
136. Lee Y C G, Wilson CJ, Winship IM, Veale AG: Marfanoid habitus, dysmorphic features, and web neck. South Med J 2000;93:1197-1200.
137. Singh KK, Rommel K, Mishra A, Karck M, Haverich A, et al: TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat 2006;27:770-777. (Pubitemid 44205070)
138. Tran-Fadulu V, Pannu H, Kim DH, Vick III GW, Lonsford CM, et al: Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet 2009;46:607-613.
139. Sood S, Eldadah ZA, Krause WL, McIntosh I, Dietz HC: Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet 1996;12:209-211.
140. Watanabe Y, Yano S, Koga Y, Yukizane S, Nishiyori A, et al:P1148A in fibrillin-1 is not a mutation leading to Shprintzen-Goldberg syndrome. Hum Mutat 1997;10:326-327.
141. Whiteman P, Downing AK, Handford PA: NMR analysis of cbEGF domains gives new insights into the structural consequences of a P1148A substitution in fibrillin-1. Protein Eng 1998;11:957-959. (Pubitemid 28548488)
142. Hewett DR, Lynch JR, Child A, Sykes BC: A new missense mutation of fibrillin in a patient with Marfan syndrome. J Med Genet 1994;31:338-339. (Pubitemid 24127538)
143. Kosaki K, Takahashi D, Udaka T, Kosaki R, Matsumoto M, et al: Molecular pathology of Shprintzen-Goldberg syndrome. Am J Med Genet A 2006;140 A: 104-108.
144. Van Steensel M A M, Van Geel M, Parren L J M T, Schrander-Stumpel C T R M, Marcus-Soekarman D: Shprintzen-Goldberg syndrome associated with a novel missense mutation in TGFBR2. Exp Dermatol 2008;17:362-365. (Pubitemid 351338681)
145. Stheneur C, Collod-Béroud G, Faivre L, Gouya L, Sultan G, et al: Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat 2008;29:E284-E295.
146. Adès LC, Sullivan K, Biggin A, Haan EA, Brett M, et al: FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. Am J Med Genet A 2006;140 A: 1047-1058.
147. Cohen MM Jr: Other syndromes with craniosynostosis; in Cohen MM Jr, MacLean RE (eds): Craniosynostosis: Diagnosis, Evaluation, and Management, 2nd ed. New York, Oxford University Press, 2000, pp 385-440.
148. Gupta AK, Koley S, Choudhary S, Bhake A, Saoji V, Salodkar A: A rare association of acanthosis nigricans with Crouzon syndrome. Indian J Dermatol Venereol Leprol 2010;76:65-67.